Ticker: RTRX
Retrophin, Inc.
$24.24
(+88.64%)
Since 2019
$
Real time stock price updated as of November 18, 2020, 6:00 PM
The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years.

Invest in Retrophin, Inc. on Stash
Retrophin, Inc. is a biopharmaceutical company.
Thanks to fractional shares
Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance.
Read more
Historical stock performance
Last 1 week | 1.0% |
Last 1 month | 13.32% |
Last 12 months | 86.25% |
Last 3 years | 5.02% |
Last 5 years | 3.87% |
Last 10 years | 39.0% |
Last 15 years | 2.72% |
Since inception | 2.72% |
The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years.
Retrophin, Inc. stock News
This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites.
Business Insider
39 minutes ago
AstraZeneca gains after its COVID-19 vaccine produced immune response in elderly, Oxford study shows
Another batch of encouraging data on the COVID-19 vaccine front was released on Thursday, this time from AstraZeneca. Shares in the UK-based drug maker gained in early Thursday trades, up as much as 1% following news that its COVID-19 vaccine showed a strong immune response in elderly patients, according to Phase II trial findings published in the Lancet medical journal.
24/7 Wall Street
40 minutes ago
Can Anything Give Macy's Stock a Shot in the Arm?
Macy's Inc. (NYSE: M) reported third-quarter 2020 results before markets opened Thursday.
CNBC
about 3 hours ago
Macy's same-store sales fall 20%, as department stores fall out of favor with shoppers during the pandemic
See It Market
about 13 hours ago
Is it Time for Oil and Gas Exploration Stocks to Wake Up?
Today Goldman Sachs announced that commodities were poised for a bull market. We have taken advantage of that bull market for quite some time now.
Why invest on Stash?
Invest affordably.
You can buy pieces of stocks and funds with any dollar amount—and our subscription plans start at just $1 per month.
Enjoy unlimited trading.
Unlike other investing apps, Stash also doesn't charge any add-on trading commissions or electronic statement fees.1
Learn how to invest.
We'll help teach you how to invest confidently through tips, articles, and ongoing personalized guidance.
Stay diversified.
We can help guide you through building a custom balanced portfolio with our
1Stash may incur ancillary fees charged by Stash and/or its custodian that are not included in the monthly Wrap-Fee.
How to buy Retrophin, Inc. stock on Stash
1. Enter the amount you'd like to invest in Retrophin, Inc. stock, then proceed to checkout.
Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.
Read more
2. Choose a Stash plan and set up your investment account in just a few minutes.
Stash offers three subscription plans: Stash Beginner, Stash Growth, and Stash+. Our Beginner plan starts at just $1 per month.
Read more
3. Once you’ve finished your account, your Retrophin, Inc. shares will be added to your new portfolio.
Once your market order of Retrophin, Inc. stock is complete, you'll officially be a shareholder of Retrophin, Inc.!
Read more

Invest in Retrophin, Inc. on Stash
Retrophin, Inc. is a biopharmaceutical company.
Thanks to fractional shares
Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance.
Read more
Stash resources for confident investing

How to Start Investing
Getting started in the world can be intimidating. Take a look at some of these basics we put together so you can learn how to start investing.

Investing in Fractional Shares on Stash
Good news: Learn how fractional shares can make an investment a lot more affordable.

Here’s How to Research Stocks
Consider P/E ratio, profit and loss, and news when buying stocks.

Subscribe to The Wallet!
Looking for financial guidance? Check your Wallet. Every week, your inbox will be packed with market savviness and clever money management techniques. Sign up today!
More Health Care stocks

CRY
CryoLife Inc
CryoLife, Inc (CryoLife) is a medical device manufacturer and processor, and is engaged in the distribution of medical devices and implantable human tissues used in cardiac surgical procedures

CPSI
Computer Programs and Systems Inc
Computer Programs and Systems, Inc. (CPSI) is a provider of healthcare information technology (IT) solutions for rural and community hospitals, and post-acute care facilities.

KPTI
Karyopharm Therapeutics, Inc.
Karyopharm Therapeutics Inc. is an oncology-focused pharmaceutical company.

MRK
Merck
Merck & Co , Inc is a global healthcare company

RVP
Retractable Technologies, Inc.
Retractable Technologies, Inc. designs, develops and manufactures safety medical products for the healthcare industry.

SGMO
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc., formerly Sangamo BioSciences, Inc.
147k+ reviews on App Store and Google Play™ Store
Over 3 million Americans use Stash to invest, save, and spend.
This is not an endorsement or a statement of satisfaction.